Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: A case report

被引:8
作者
Tashiro H. [1 ]
Takahashi K. [1 ]
Nakamura T. [1 ]
Komiya K. [1 ]
Kimura S. [1 ]
Sueoka-Aragane N. [1 ]
机构
[1] Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga
关键词
IgG4-related disease; Lung cancer; Lung nodule;
D O I
10.1186/s13256-016-0898-3
中图分类号
学科分类号
摘要
Background: Immunoglobulin G4-related disease is characterized by infiltration of immunoglobulin G4-positive plasmacytes in various organs. The radiological findings of lung involvement of immunoglobulin G4-related disease include hilar and mediastinal lymphadenopathies, thickness of bronchovascular bundles, peribronchovascular consolidation, and lung nodules. Although a pathological approach is needed to diagnose immunoglobulin G4-related disease, it is ordinarily diagnosed by biopsy from one lesion even if there are multiple lesions. We reported a rare case of the coexistence of immunoglobulin G4-related disease and lung cancer in the same lung nodule. Case presentation: A 72-year-old Japanese man visited our hospital for evaluation of a nodular shadow in the middle lobe of his right lung that was seen on chest radiograph and computed tomography scan. An abdominal computed tomography scan showed a tumefactive lesion in his anterior sacral spine. Blood examinations revealed high serum immunoglobulin G4 concentration at 346 mg/dl, renal dysfunction, and anemia. He underwent right upper lobectomy and regional lymph node dissection. Pathologic findings of the lung nodule showed lepidic pattern adenocarcinoma with infiltration of immunoglobulin G4-positive plasma cells and obliterative phlebitis. Conclusions: To date, there have been only few reports on the coexistence of immunoglobulin G4-related disease and lung cancer; here, we report such a rare case. Histologic examination should be considered in cases of suspicious immunoglobulin G4-related disease appearing in a lung nodule. © 2016 Tashiro et al.
引用
收藏
相关论文
共 10 条
  • [1] Kamisawa T., Zen Y., Pillai S., Stone J.H., IgG4-related disease, Lancet, 385, 9976, pp. 1460-1471, (2015)
  • [2] Deshpande V., Zen Y., Chan J.K., Yi E.E., Sato Y., Yoshino T., Et al., Consensus statement on the pathology of IgG4-related disease, Mod Pathol, 25, 9, pp. 1181-1192, (2012)
  • [3] Campbell S.N., Rubio E., Loschner A.L., Clinical review of pulmonary manifestations of IgG4-related disease, Ann Am Thorac Soc, 11, 9, pp. 1466-1475, (2014)
  • [4] Matsui S., Hebisawa A., Sakai F., Yamamoto H., Terasaki Y., Kurihara Y., Et al., Immunoglobulin G4-related lung disease: Clinicoradiological and pathological features, Respirology, 18, 3, pp. 480-487, (2013)
  • [5] Fujinaga Y., Kadoya M., Kawa S., Hamano H., Ueda K., Momose M., Et al., Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis, Eur J Radiol, 76, 2, pp. 228-238, (2010)
  • [6] Kitada M., Matuda Y., Hayashi S., Ishibashi K., Oikawa K., Miyokawa N., Et al., IgG4-related lung disease showing high standardized uptake values on FDG-PET: Report of two cases, J Cardiothorac Surg., 8, (2013)
  • [7] Inoue D., Zen Y., Abo H., Gabata T., Demachi H., Kobayashi T., Et al., Immunoglobulin G4-related lung disease: CT findings with pathologic correlations, Radiology, 251, 1, pp. 260-270, (2009)
  • [8] Matsui S., Taki H., Shinoda K., Suzuki K., Hayashi R., Tobe K., Et al., Respiratory involvement in IgG4-related Mikulicz's disease, Mod Rheumatol, 22, 1, pp. 31-39, (2012)
  • [9] Yamamoto M., Takahashi H., Tabeya T., Suzuki C., Naishiro Y., Ishigami K., Et al., Risk of malignancies in IgG4-related disease, Mod Rheumatol, 22, 3, pp. 414-418, (2012)
  • [10] Inoue T., Hayama M., Kobayashi S., Oyaizu T., Nakazato Y., Honma K., Et al., Lung cancer complicated with IgG4-related disease of the lung, Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 20, pp. 474-477, (2014)